Hisami Fukuda

A Phase II Trial of Chemoradiotherapy for Stage I Esophageal Squamous Cell Carcinoma: Japan Clinical Oncology Group Study (JCOG9708)

Hoichi Kato, Akihiro Sato, Hisami Fukuda et al. · Japanese Journal of Clinical Oncology · 2009 · 291 citations

Impact of<i>IGF-I</i>and<i>CYP19</i>Gene Polymorphisms on the Survival of Patients With Metastatic Prostate Cancer

Norihiko Tsuchiya, Lizhong Wang, Hiroyoshi Suzuki et al. · Journal of Clinical Oncology · 2006 · 75 citations · Full text

Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer

Tomonori Habuchi, Osamu Ogawa, Shigeru Satoh et al. · Oncology Reports · 2007 · 33 citations · Full text

Effect of Levofloxacin on the Efficacy and Adverse Events in Intravesical Bacillus Calmette-Guerin Treatment for Bladder Cancer: Results of a Randomized, Prospective, Multicenter Study

Kazuyuki Numakura, Mizuki Kobayashi, Toshiya Ishida et al. · European Urology Focus · 2022 · 13 citations

Adverse Events, Urology, Urological Research +7

A multicenter randomized phase II (rPII)/III study comparing concurrent chemoradiotherapy (CRT) with low-dose cisplatin plus continuous infusion of 5-fluorouracil (LDPF) and standard-dose PF (SDPF) for locally advanced unresectable squamous cell carcinoma of the thoracic esophagus (JCOG0303).

M. Shinoda, N Ando, Hidenori Kato et al. · Journal of Clinical Oncology · 2010 · 10 citations

Esophageal Cancer, Cisplatin-based Crt, Ldpf Group +17